In addition, they will be capping the out-of-pocket cost at $35.

The announcement builds on the Lilly Insulin Value Program, which was launched in 2020.

Members of that program were already eligible to receive their insulin at $35 a month or less.

Vector Illustration Showing Insulin and Pen Syringe

Photo: TAlexey/Depositphotos

But the new guidelines will bring these savings to even more people.

Now, anyone with commercial insurance will receive their prescription at $35 or less through most retail pharmacies.

Anyone who is uninsured or uses a non-participating pharmacy can still benefit from the deal bydownloading a savings card.

The aggressive price cuts we’re announcing today should make a real difference for Americans with diabetes

Huge news.

Last year, we capped insulin prices for seniors on Medicare, but there was more work to do.

I called on Congress and manufacturers to lower insulin prices for everyone else.

Today, Eli Lilly is heeding my call.

But there are other discounts coming even sooner.

According to Eli Lilly, this will make it the lowest list-priced mealtime insulin available.

President Joe Biden seems encouraged by the change, calling it a big deal, in a statement.

At the same time, he encouraged pharmaceutical companies to bring down the retail cost of the drug.

These changes couldn’t come at a better time.

Diabetes is one of the fastest-growing chronic illnesses in the United States.

Prediabetes raises the risk for punch in 2 diabetes, as well as heart disease and stroke.

In these cases, a lifestyle change can stave off diabetes and prevent the need for medication.

I did a… certain tweet two weeks ago.

You probably saw it.

So, Morrow did just that with an old account he renamed @EliLillyandCo.

Eli Lilly had to send out a public statement denying this change and admitting to their high insulin prices.

After this admission,stock prices dropped 4.37%for the pharmaceutical company.

Though they’ve made some positive changes in the end, many people question their motives.